CHOC selected as West Coast site for gene therapy clinical trial for patients 8 years and older with Glycogen Storage Disease type 1a.
CHOC colorectal experts talk Hirschsprung disease, anorectal malformation
CHOC’s pediatric colorectal program makes a significant impact on children with treatments and tools for correcting colorectal issues.
First-of-its-kind study links mechanical bull riding with pediatric head injuries
A first-of-its-kind study by CHOC found that awareness and safety precautions are vital to prevent severe injuries from mechanic bull riding.
Device for patients with GI issues showing promise in treating Post-Concussion Syndrome
CHOC doctors discover the possible efficacy of treating PCS with the GI device IB-Stim. A clinical trial is underway.
Medical device research leads to improved neonatal care
A partnership between CHOC and Masimo has developed technology to noninvasively monitor blood oxygen and hemoglobin levels in newborns.
Enzyme replacement therapy slows progression of CLN2 Disease
CHOC is at the forefront to offer breakthrough enzyme replacement therapy to improve the quality of life for children with CLN2.
